The ???Uber of Biotech??? Gets Back To Work

Hilary Kramer discusses biotech stocks, outlines their risks and compares the industry leader to Uber.

  • by:
  • 08/21/2022

By Hilary Kramer

Forget the ???FANG??? group of the biggest technology companies. When you want pure disruptive innovation and a wild Wall Street ride, biotech remains the place to be.

I love these stocks. When they???re rallying, they???re a play on pure innovation. This is because they generate wealth for shareholders on what boils down to the confidence that medical science will keep advancing.

The upside is practically infinite. After all, most computer tools only improve life in increments, make us a little more productive day by day and expand our existing reach.

Biotech, at its most visionary, saves human lives that otherwise would be cut short one way or another. That transcends normal valuations.

Companies that develop those therapies can one day be worth the price of progress itself. And when that mood catches on, the stocks soar.

We???ve seen a few of these stocks on my Turbo Trader list soar 50 percent year to date. That???s true transformative upside. It???s exhilarating.

Click here to read more.

Image:
ADVERTISEMENT

Opinion

View All

KENNY CODY: The Hunter Biden and Pete Hegseth dichotomy sums up the GOP's problem

When push comes to shove, for some reason, the GOP always wants to be the party that wants to get run...

HUMAN EVENTS: Is the BLM era over?

Certainly, the early signs are encouraging....

JACK POSOBIEC and DARREN BEATTIE: We should 'repurpose' inefficient bureaucratic offices rather than scrap them

"Imagine if the GEC were commandeered by somebody who thinks along our lines, who repurposes it for a...

Gay founders of Pink News accused of sexual misconduct by staffers

Lawyers for Anthony James and Benjamin Cohen, the gay couple who founded PinkNews, have denied the al...